A selective T-type Ca2+ channel blocker R(-) efonidipine
Min-Chul Shin1, Chang-Ju Kim, Byung-Il Min
1Research Division for Life Sciences, Kumamoto Health Science University, Kumamoto, 861-5598, Japan.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|February 19, 2008
Summary
R(-) efonidipine selectively blocks low-voltage-activated (T-type) calcium channels in the central nervous system. Unlike other drugs, it does not affect high-voltage-activated channels, making it a valuable research tool.
Area of Science:
- Neuropharmacology
- Ion Channel Physiology
Background:
- Low-voltage-activated (T-type) Ca2+ channels are crucial in the peripheral nervous system.
- Understanding their role in the central nervous system (CNS) requires specific pharmacological tools.
Purpose of the Study:
- To investigate the effects of R(-) efonidipine on T-type and high-voltage-activated (HVA) Ca2+ channels in mammalian CNS neurons.
- To compare R(-) efonidipine's selectivity with flunarizine and mibefradil.
Main Methods:
- Utilized the nystatin perforated-patch clamp technique.
- Examined effects on rat hippocampal CA1 neurons.
- Tested blockade of T-type and HVA Ca2+ channels.
Main Results:
- R(-) efonidipine selectively inhibited T-type Ca2+ channels without affecting HVA Ca2+ channels.
- Flunarizine and mibefradil nonselectively inhibited both T-type and HVA Ca2+ channels.
- R(-) efonidipine did not inhibit voltage-dependent Na+ or Ca2+-activated K+ channels, unlike flunarizine.
Conclusions:
- R(-) efonidipine is a highly selective blocker of T-type Ca2+ channels.
- Its specificity makes it a promising pharmacological tool for future research on T-type Ca2+ channel functions.
More Related Videos
Related Concept Videos
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...